Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 77 citing articles:

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam, Seran Hakki, Jake Dunning, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 183-195
Open Access | Times Cited: 753
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e229317-e229317
Open Access | Times Cited: 203
Ethnic/racial minorities’ and migrants’ access to COVID-19 vaccines: A systematic review of barriers and facilitators
Mohammed Abba-Aji, David Stuckler, Sandro Galea, et al.
Journal of Migration and Health (2022) Vol. 5, pp. 100086-100086
Open Access | Times Cited: 133
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Eurosurveillance (2021) Vol. 26, Iss. 39
Open Access | Times Cited: 69
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
Brechje de Gier, Stijn P. Andeweg, Jantien A. Backer, et al.
Eurosurveillance (2021) Vol. 26, Iss. 44
Open Access | Times Cited: 69
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study
Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 585-592
Open Access | Times Cited: 62
Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study
Maylis Layan, Mayan Gilboa, Tal Gonen, et al.
American Journal of Epidemiology (2022) Vol. 191, Iss. 7, pp. 1224-1234
Open Access | Times Cited: 51
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222959-e222959
Open Access | Times Cited: 51
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary Kate Morris, Alicia Sotomayor-González, et al.
Nature Microbiology (2022) Vol. 7, Iss. 2, pp. 277-288
Open Access | Times Cited: 44
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study
Anne J. Huiberts, Brechje de Gier, Christina E. Hoeve, et al.
International Journal of Infectious Diseases (2023) Vol. 133, pp. 36-42
Open Access | Times Cited: 22
Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China
Kai Wang, Zihao Guo, Ting Zeng, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e235755-e235755
Open Access | Times Cited: 21
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective
Jasmine R Marcelin, Audrey Pettifor, Holly Janes, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 34
Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals
Stijn P. Andeweg, Harry Vennema, Irene Veldhuijzen, et al.
Science Translational Medicine (2022) Vol. 15, Iss. 684
Open Access | Times Cited: 33
The risk of miscarriage following COVID-19 vaccination: a systematic review and meta-analysis
Michael P. Rimmer, Jhia Jiat Teh, Scott C. Mackenzie, et al.
Human Reproduction (2023) Vol. 38, Iss. 5, pp. 840-852
Open Access | Times Cited: 20
COVID-19, social determinants of transmission in the home. A population-based study
Jesús Soriano López, Jesús Humberto Gómez Gómez, Mónica Ballesta-Ruiz, et al.
European Journal of Public Health (2024) Vol. 34, Iss. 3, pp. 427-434
Open Access | Times Cited: 5
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
Carolyn T. Bramante, Jennifer Proper, David R. Boulware, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 25
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2022) Vol. 40, Iss. 22, pp. 3027-3037
Open Access | Times Cited: 23
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
Samuel Clifford, Pauline Waight, Jada Hackman, et al.
Wellcome Open Research (2023) Vol. 8, pp. 96-96
Open Access | Times Cited: 14
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April- August 2021
Brechje de Gier, Marjolein N. Kooijman, Jeanet M. Kemmeren, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 31
COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA
Thomas N. Vilches, Pratha Sah, Seyed M. Moghadas, et al.
The Lancet Regional Health - Americas (2021) Vol. 6, pp. 100147-100147
Open Access | Times Cited: 28
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
Zhujun Ao, Maggie Jing Ouyang, Titus Abiola Olukitibi, et al.
Journal of Virology (2022) Vol. 96, Iss. 18
Open Access | Times Cited: 20
SARS-CoV-2 infection and immune responses
Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 245-276
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top